|

Pucotenlimab Clinical Trials

4 actively recruiting trials

Pipeline

Phase 2: 2Phase 1/2: 2

Top Sponsors

  • Sun Yat-sen University2
  • Zhejiang Provincial People's Hospital1
  • Second Affiliated Hospital, School of Medicine, Zhejiang University1

Indications

  • Cancer4
  • Proterizumab1
  • LDRT1
  • PD-L11
  • PD-1 Inhibitor1

Other4 trials

Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
Phase 1/2
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
Phase 1/2
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Phase 2
Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.